JAGX Earnings Jaguar Health, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–33 of 33
| Q2 2026 | 2026-06-30 | -3532.50 | 2026-08-19 | 10-Q |
| Q1 2026 | 2026-03-31 | -3060.00 | 2026-05-20 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 80829.00 | 2026-04-07 | 10-K |
| FY 2025 | 2025-12-31 | -180888.75 | 2026-04-07 | 10-K |
| Q3 2025 | 2025-09-30 | -49455.00 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -80761.50 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -131501.25 | 2025-05-15 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -115132.50 | 2025-03-31 | 10-K |
| FY 2024 | 2024-12-31 | -1029183.75 | 2025-03-31 | 10-K |
| Q3 2024 | 2024-09-30 | -207033.75 | 2024-11-13 | 10-Q |
| Q2 2024 | 2024-06-30 | -20947.50 | 2024-08-13 | 10-Q |
| Q1 2024 | 2024-03-31 | -686070.00 | 2024-05-14 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 38533005.00 | 2024-04-01 | 10-K |
| FY 2023 | 2023-12-31 | -21090588.75 | 2024-04-01 | 10-K |
| Q3 2023 | 2023-09-30 | -4429687.50 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -8140781.25 | 2023-08-14 | 10-Q |
| Q1 2023 | 2023-03-31 | -47053125.00 | 2023-05-15 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 88987500.00 | 2023-03-24 | 10-K |
| FY 2022 | 2022-12-31 | -712293750.00 | 2023-03-24 | 10-K |
| Q3 2022 | 2022-09-30 | -173840625.00 | 2022-11-14 | 10-Q |
| Q2 2022 | 2022-06-30 | -172659375.00 | 2022-08-22 | 10-Q |
| Q1 2022 | 2022-03-31 | -454781250.00 | 2022-05-10 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -1719900000.00 | 2022-03-11 | 10-K |
| FY 2021 | 2021-12-31 | -1736831250.00 | 2022-03-11 | 10-K |
| Q3 2021 | 2021-09-30 | -5315625.00 | 2021-11-17 | 10-Q |
| Q2 2021 | 2021-06-30 | -6103125.00 | 2021-08-13 | 10-Q |
| Q1 2021 | 2021-03-31 | -5512500.00 | — | — |
| FY 2020 | 2020-12-31 | -59062500.00 | — | — |
| Q3 2020 | 2020-09-30 | -12206250.00 | — | — |
| Q2 2020 | 2020-06-30 | -8662500.00 | — | — |
| Q3 2018 | 2018-09-30 | -10040625.00 | 2018-11-19 | 10-Q |
| Q3 2017 | 2017-09-30 | 21853125.00 | 2017-11-20 | 10-Q |
| Q3 2016 | 2016-09-30 | -5906250.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.